Your browser doesn't support javascript.
loading
Recurrent mutations in epigenetic modifiers and the PI3K/AKT/mTOR pathway in subcutaneous panniculitis-like T-cell lymphoma.
Li, Zhaoming; Lu, Lisha; Zhou, Zhiyuan; Xue, Weili; Wang, Yingjun; Jin, Mengyuan; Qiu, Yajuan; Sun, Wei; Fu, Xuefei; Zhang, Xudong; Chang, Yu; Nan, Feifei; Yan, Jiaqin; Wang, Guannan; Sun, Zhenchang; Fu, Xiaorui; Li, Ling; Li, Xin; Wang, Xinhua; Wu, Jingjing; Zhang, Lei; Zhang, Mingzhi.
Afiliación
  • Li Z; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Lu L; Lymphoma Diagnosis and Treatment Centre of Henan Province, Zhengzhou, China.
  • Zhou Z; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Xue W; Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Wang Y; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Jin M; Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Qiu Y; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Sun W; Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Fu X; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Zhang X; Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Chang Y; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Nan F; Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Yan J; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Wang G; Lymphoma Diagnosis and Treatment Centre of Henan Province, Zhengzhou, China.
  • Sun Z; Novogene Bioinformatics Technology Co, Ltd, Beijing, China.
  • Fu X; Novogene Bioinformatics Technology Co, Ltd, Beijing, China.
  • Li L; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Li X; Lymphoma Diagnosis and Treatment Centre of Henan Province, Zhengzhou, China.
  • Wang X; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Wu J; Lymphoma Diagnosis and Treatment Centre of Henan Province, Zhengzhou, China.
  • Zhang L; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Zhang M; Lymphoma Diagnosis and Treatment Centre of Henan Province, Zhengzhou, China.
Br J Haematol ; 181(3): 406-410, 2018 05.
Article en En | MEDLINE | ID: mdl-28294301
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Paniculitis / Transducción de Señal / Linfoma Cutáneo de Células T / Fosfatidilinositol 3-Quinasas / Epigénesis Genética / Proteínas Proto-Oncogénicas c-akt / Serina-Treonina Quinasas TOR / Mutación Límite: Female / Humans / Male Idioma: En Revista: Br J Haematol Año: 2018 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Paniculitis / Transducción de Señal / Linfoma Cutáneo de Células T / Fosfatidilinositol 3-Quinasas / Epigénesis Genética / Proteínas Proto-Oncogénicas c-akt / Serina-Treonina Quinasas TOR / Mutación Límite: Female / Humans / Male Idioma: En Revista: Br J Haematol Año: 2018 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido